Both agents influence glucose metabolism via different pathways, creating a theoretical risk of unpredictable glycaemic instability
Attempts to redefine these terms in the endocrinology field and diabetes sub terminology, may potentially create more ambiguity
Ozempic for CKD and heart disease The FLOW phase 3b clinical trial (NCT03819153) demonstrated that when Ozempic 1 mg injection was used in adults with type 2 diabetes and CKD, Ozempic demonstrated: 24% reduced the risk of kidney disease progression, kidney failure, and cardiovascular death at 3 years when compared to placebo
She also liked how non-threatening the product looked
17 Menopause increases the risk of cardiometabolic diseases like type 2 diabetes mellitus (T2DM), high cholesterol levels, fatty liver, and cardiovascular disease (CVD), the latter being the leading killer among women